Digestives & Intestinal Remedies - United Arab Emirates

  • United Arab Emirates
  • In the United Arab Emirates, the revenue generated in the Digestives & Intestinal Remedies market market reached US$60.36m in 2024.
  • It is projected to experience an annual growth rate of 3.99% (CAGR 2024-2029).
  • When compared globally, in China generates the highest revenue in this market, amounting to US$4,408.00m in 2024.
  • Taking into account the total population figures, the per person revenue in the United Arab Emirates stands at US$6.29 in 2024.
  • In the United Arab Emirates, there is a growing demand for natural and herbal digestive remedies in the OTC Pharmaceuticals market.

Key regions: Canada, United States, Australia, Brazil, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestives & Intestinal Remedies market in United Arab Emirates is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in United Arab Emirates are increasingly seeking natural and herbal remedies for digestive issues. This shift in preference can be attributed to a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for digestive supplements and herbal remedies that promote gut health and aid in digestion.

Trends in the market:
One of the key trends in the Digestives & Intestinal Remedies market in United Arab Emirates is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and improve overall digestion. The demand for probiotic supplements and foods has been on the rise as consumers become more aware of the benefits of maintaining a healthy gut microbiome.Another trend in the market is the growing interest in natural and organic products. Consumers are becoming more conscious of the ingredients used in digestive remedies and are seeking products that are free from artificial additives and preservatives. This has led to an increase in the availability of natural and organic digestive remedies in the market.

Local special circumstances:
United Arab Emirates has a large expatriate population, with people from various countries residing in the country. This diversity in the population has led to a demand for digestive remedies that cater to different cultural preferences and dietary habits. Manufacturers and retailers are adapting to this demand by offering a wide range of products that cater to specific dietary needs and preferences.

Underlying macroeconomic factors:
The growing economy of United Arab Emirates has increased the purchasing power of consumers, allowing them to spend more on healthcare and wellness products. This has contributed to the growth of the Digestives & Intestinal Remedies market in the country. Additionally, the government's focus on promoting healthcare and wellness initiatives has further boosted the market, as consumers are encouraged to take a proactive approach towards their digestive health.In conclusion, the Digestives & Intestinal Remedies market in United Arab Emirates is witnessing growth due to changing customer preferences towards natural and herbal remedies, emerging trends such as the popularity of probiotics and organic products, local special circumstances of a diverse population, and underlying macroeconomic factors such as a growing economy and government initiatives.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)